Search research articles
Contact Us
Filters
Showing results (591-600 of 651) with videos related to
Page
of 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial
Michael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Hemasphere
|
April 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma
Jan H Frenking, Christine Riedhammer, Raphael Teipel, et al.
Nature Medicine
|
July 1, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agent
Julian Zoller, Michael Kalz, Xuewei Wu, et al.
The Journal of Clinical Investigation
|
January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantation
Christian Morath, Anita Schmitt, Christian Kleist, et al.
Communications Medicine
|
May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Nature Communications
|
November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
Raphael Lutz, Florian Grünschläger, Malte Simon, et al.
Journal of the American Society of Nephrology : JASN
|
September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients
Christian Morath, Matthias Schaier, Eman Ibrahim, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 2022
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
Maher Hanoun, Leo Ruhnke, Michael Kramer, et al.
Haematologica
|
June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Scientific Reports
|
March 14, 2019
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Michael P Schroeder, Lorenz Bastian, Cornelia Eckert, et al.
Page
of 66
Search research articles
Search
Showing results (591-600 of 651) with videos related to
Sort By:
Page
of 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2019
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial
Michael Lübbert, Olga Grishina, Claudia Schmoor, et al.
Hemasphere
|
April 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma
Jan H Frenking, Christine Riedhammer, Raphael Teipel, et al.
Nature Medicine
|
July 1, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agent
Julian Zoller, Michael Kalz, Xuewei Wu, et al.
The Journal of Clinical Investigation
|
January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantation
Christian Morath, Anita Schmitt, Christian Kleist, et al.
Communications Medicine
|
May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Nature Communications
|
November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
Raphael Lutz, Florian Grünschläger, Malte Simon, et al.
Journal of the American Society of Nephrology : JASN
|
September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients
Christian Morath, Matthias Schaier, Eman Ibrahim, et al.
Journal of Cancer Research and Clinical Oncology
|
September 28, 2022
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
Maher Hanoun, Leo Ruhnke, Michael Kramer, et al.
Haematologica
|
June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Scientific Reports
|
March 14, 2019
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
Michael P Schroeder, Lorenz Bastian, Cornelia Eckert, et al.
Page
of 66